编码中东呼吸综合征冠状病毒S1蛋白的DNA疫苗在小鼠中诱导保护性免疫应答
研究显示编码MERS-CoV刺突蛋白前725个氨基酸(S1)的DNA疫苗可在小鼠中诱导体液和细胞免疫应答,三次免疫后无需佐剂即产生高达1:10⁴的中和抗体滴度;pcDNA3.1-S1免疫及被动转移免疫血清均保护Ad5-hDPP4转导小鼠免受MERS-CoV攻击。
要点
- 编码MERS-CoV S1蛋白的DNA疫苗三次免疫小鼠后无需佐剂即诱导高滴度中和抗体(高达1:10⁴)。
- DNA疫苗接种显著增加分泌IFN-γ及其他细胞因子的抗原特异性CD4+和CD8+ T细胞频率。
- pcDNA3.1-S1免疫和被动转移免疫血清均保护Ad5-hDPP4转导小鼠免受MERS-CoV攻击。
核心结论
- 编码MERS-CoV S1蛋白的DNA疫苗诱导针对MERS-CoV感染的强保护性免疫应答。
研究设计与样本
- 小鼠实验研究:编码MERS-CoV刺突蛋白前725个氨基酸(S1)的DNA疫苗(pcDNA3.1-S1)三次免疫小鼠,并用Ad5-hDPP4转导小鼠进行MERS-CoV攻击保护实验。
主要发现
- 三次免疫后无需佐剂即产生高滴度中和抗体(高达1:10⁴)。
- DNA疫苗接种显著增加分泌IFN-γ及其他细胞因子的抗原特异性CD4+和CD8+ T细胞频率。
- pcDNA3.1-S1 DNA疫苗免疫和被动转移pcDNA3.1-S1免疫小鼠血清均保护Ad5-hDPP4转导小鼠免受MERS-CoV攻击。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Middle East respiratory syndrome coronavirus (MERS-CoV), is an emerging pathogen that continues to cause outbreaks in the Arabian peninsula and in travelers from this region, raising the concern that a global pandemic could occur. Here, we show that a DNA vaccine encoding the first 725 amino acids (S1) of MERS-CoV spike (S) protein induces antigen-specific humoral and cellular immune responses in mice. With three immunizations, high titers of neutralizing antibodies (up to 1: 104) were generated without adjuvant. DNA vaccination with the MERS-CoV S1 gene markedly increased the frequencies of antigen-specific CD4+ and CD8+ T cells secreting IFN-γ and other cytokines. Both pcDNA3.1-S1 DNA vaccine immunization and passive transfer of immune serum from pcDNA3.1-S1 vaccinated mice protected Ad5-hDPP4-transduced mice from MERS-CoV challenge. These results demonstrate that a DNA vaccine encoding MERS-CoV S1 protein induces strong protective immune responses against MERS-CoV infection.
引用
- Chi H, Zheng X, Wang X, et al. DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice. Vaccine. 2017. PMID: 28314561. doi:10.1016/j.vaccine.2017.02.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。